Analysts at Truist Financial assumed coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) in a research note issued on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $22.00 price target on the stock. Truist Financial’s target price indicates a potential upside of 22.15% from the company’s current price.
Guardian Pharmacy Services Stock Up 0.1 %
GRDN opened at $18.01 on Monday. Guardian Pharmacy Services has a 52-week low of $14.16 and a 52-week high of $20.10.
Insider Transactions at Guardian Pharmacy Services
In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was purchased at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the purchase, the director now owns 35,714 shares of the company’s stock, valued at approximately $499,996. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
Institutional Trading of Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Comparing and Trading High PE Ratio Stocks
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Buy Cheap Stocks Step by Step
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.